Editorial
doi: 10.1093/jnci/djs462.
Epub 2012 Nov 28.
An aspirin a day: the allure (and distraction) of chemoprevention
- PMID: 23197493
- DOI: 10.1093/jnci/djs462
Item in Clipboard
Editorial
An aspirin a day: the allure (and distraction) of chemoprevention
J Natl Cancer Inst.
.
No abstract available
Similar articles
-
Wondering how the wonder drug works.Science. 2012 Sep 21;337(6101):1472. doi: 10.1126/science.337.6101.1472. Science. 2012. PMID: 22997321 No abstract available.
-
[Risk factors and prevention of hepatocellular carcinoma].Fukuoka Igaku Zasshi. 1997 Oct;88(10):325-30. Fukuoka Igaku Zasshi. 1997. PMID: 9432489 Review. Japanese. No abstract available.
-
Prevention of hepatocellular carcinoma.S Afr J Surg. 2011 Apr;49(2):50-1, 86. S Afr J Surg. 2011. PMID: 21614973 No abstract available.
-
Hepatocellular carcinoma at the cutting edge of science and practice.Minerva Med. 2010 Dec;101(6):391-3. Minerva Med. 2010. PMID: 21196898 No abstract available.
-
Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):473-84. doi: 10.1016/j.bpg.2011.10.016. Best Pract Res Clin Gastroenterol. 2011. PMID: 22122764 Review.
Cited by
-
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.JAMA Oncol. 2018 Dec 1;4(12):1683-1690. doi: 10.1001/jamaoncol.2018.4154. JAMA Oncol. 2018. PMID: 30286235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
